Single-Chamber Prefilled Syringes Market Expansion Continues, with Forecast Valuation of $22.44 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Single-Chamber Prefilled Syringes Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for single-chamber prefilled syringes has seen substantial growth recently. It is predicted to increase from a value of $10.72 billion in 2024 to $12.03 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.2%. This growth in the historic period is largely due to developments in the pharmaceutical and biotechnology sectors, the convenience of patient-specific drug administration, safety and user-friendliness, the demand for accurate drug dosage, and regulatory approvals and guidelines.

Single-Chamber Prefilled Syringes Market Size Forecast: What's the Projected Valuation by 2029?
We can expect to witness accelerated growth in the single-chamber prefilled syringes market over the next several years. This market is projected to be worth $22.44 billion by 2029, with a compound annual growth rate (CAGR) of 16.9%. The significant growth anticipated for this period could be ascribed to factors such as the use of biologics and biosimilars in prefilled syringes, trends towards self-administration and home healthcare, advancing drug delivery for pediatric and geriatric populations, the pairing of combination products with auto-injectors, and a regulatory focus on drug safety, along with telemedicine and remote monitoring. As we move forward, the forecast period is likely to see emerging trends such as connected device-compatible prefilled syringes, sustainable and biodegradable materials, options for custom and patient-specific syringes, needlestick prevention and safety enhancements, prefilled syringes designed for cell and gene therapy applications, and anti-counterfeiting measures being incorporated into prefilled syringe designs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/single-chamber-prefilled-syringes-global-market-report

What Are the Drivers Transforming the Single-Chamber Prefilled Syringes Market?
Increases in chronic ailments like diabetes and cancer are fuelling the expansion of the single-chamber prefilled syringe market. These syringes are commonly used by diabetics requiring insulin therapy when blood glucose levels cannot be regulated by medication alone. As an example, the World Health Organization, a Swiss organization focused on global public health, reported in February 2024 that there are predictions for over 35 million new cancer diagnoses by 2050. This indicates a massive 77% growth from the expected 20 million cases in 2022. Hence, the rising instances of chronic health conditions such as diabetes and cancer are indeed propelling the demand for single-chamber prefilled syringes.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5419&type=smp

What Long-Term Trends Will Define the Future of the Single-Chamber Prefilled Syringes Market?
Technological advancements continue to drive growth in the single-chamber prefilled syringe market. Key players in this sector are striving to create innovative solutions to consolidate their market position. Illustrating this trend, in September 2022, the US-based Otsuka America Pharmaceutical, Inc. and Denmark's H. Lundbeck A/S launched the Aripiprazole 2-month medication. This is a 2-month, ready-to-use, long-acting injection of aripiprazole filled in a single-chamber syringe. The recommended administration of this medication is an intramuscular injection into the gluteal muscle every two months.

Which Segments in the Single-Chamber Prefilled Syringes Market Offer the Most Profit Potential?
The single-chamber prefilled syringes market covered in this report is segmented -

1) By Type: Glass, Plastic
2) By Application: Vaccine Product, Biologic, Pharmaceutical Product

Subsegments:
1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes
2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5419&type=smp

Which Firms Dominate the Single-Chamber Prefilled Syringes Market by Market Share and Revenue in 2025?
Major companies operating in the single-chamber prefilled syringes market include Becton, Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, Weigao Group Medical Polymer Company Limited, Stevanato Group S.p.A., Baxter International Inc., Vetter Pharma International GmbH, Terumo Corporation, Ypsomed Holding AG, SHL Medical AG, Ompi, Elcam Medical A.C.S. Ltd., Oval Medical Technologies Ltd., West Pharmaceutical Services Inc., Gerresheimer Regensburg GmbH, SCHOTT North America Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Aptar Pharma Services Inc., Bespak Europe Ltd., Credence MedSystems Inc., Datwyler Pharma Packaging International Holding AG, Dätwyler Sealing Solutions AG, Fresenius Kabi AG, Haselmeier GmbH, Hikma Pharmaceuticals PLC, HTL-STREFA S.A., Intas Pharmaceuticals Ltd.

Which Regions Offer the Highest Growth Potential in the Single-Chamber Prefilled Syringes Market?
North America was the largest region in the single-chamber prefilled syringes market in 2024. Asia-Pacific was the second largest region in the single-chamber prefilled syringes market share. The regions covered in the single-chamber prefilled syringes market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5419

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.